558 related articles for article (PubMed ID: 33370413)
1. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
[TBL] [Abstract][Full Text] [Related]
2. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B.
Shen E; Zhu K; Li D; Pan Z; Luo Y; Bian Q; He L; Song X; Zhen Y; Jin D; Tao L
Commun Biol; 2020 Jul; 3(1):347. PubMed ID: 32620855
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomics of
Janezic S; Dingle K; Alvin J; Accetto T; Didelot X; Crook DW; Lacy DB; Rupnik M
Microb Genom; 2020 Oct; 6(10):. PubMed ID: 33030421
[No Abstract] [Full Text] [Related]
4. The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5.
Elliott B; Dingle KE; Didelot X; Crook DW; Riley TV
Genome Biol Evol; 2014 Nov; 6(12):3159-70. PubMed ID: 25381663
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
7. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
8. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
[TBL] [Abstract][Full Text] [Related]
9. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo.
Kordus SL; Kroh HK; Rodríguez RC; Shrem RA; Peritore-Galve FC; Shupe JA; Wadzinski BE; Lacy DB; Spiller BW
PLoS Pathog; 2023 Oct; 19(10):e1011496. PubMed ID: 37871122
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.
Stabler RA; Dawson LF; Phua LTH; Wren BW
J Med Microbiol; 2008 Jun; 57(Pt 6):771-775. PubMed ID: 18480336
[TBL] [Abstract][Full Text] [Related]
12. Detection and elimination of a novel non-toxigenic
Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
[No Abstract] [Full Text] [Related]
13. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
[TBL] [Abstract][Full Text] [Related]
15. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
16. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
17. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
18. The Importance of Therapeutically Targeting the Binary Toxin from
Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
Wang S; Heuler J; Wickramage I; Sun X
Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
[TBL] [Abstract][Full Text] [Related]
20. A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from
Sapa D; Brosse A; Coullon H; Péan de Ponfilly G; Candela T; Le Monnier A
Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38251254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
